Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Ethnopharmacol ; 171: 121-4, 2015 Aug 02.
Article in English | MEDLINE | ID: mdl-26068422

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Areca catechu Linn. (Arecaceae) nut is a popular folk remedy for the treatment of migraine in Kerala and Tamil Nadu states of India. AIM OF THE STUDY: This study was designed to investigate the effect of hydroalcoholic extract of A. catechu L. nut (ANE) treatment on migraine pain in rat models to strengthen its use as an anti-migraine therapy. MATERIALS AND METHODS: Bradykinin (0.1 µmol/kg) injection in to left femoral vein of rat produced PPE which was measured with luminescence spectrometer. Vocalizations were produced in rats with 10 µg of bradykinin infusion into common carotid artery. Phonogram was recorded before, during and for 5min after bradykinin injection and sumatriptan was used as a standard anti-migraine drug. In both models, the ANE was orally administered at doses of 250 and 500 mg/kg, 60 min before bradykinin infusion. RESULTS: The PPE was reduced in both ANE treated groups of rats. The percent fluorescein was significantly increased in positive control group (97.00±1.7%; p<0.0001) compared to negative control (63.87±1.2%). With ANE treatments (250 and 500 mg/kg) PPE was significantly decreased to 88.88±1.4% (p<0.01) and 83.55±0.1% (p<0.0001) compared to positive control group, respectively. On the other hand in the model of vocalization, with 250 and 500 mg/kg ANE treatment, vocalization was significantly reduced to 33.33% and 16.66%, respectively, compared to saline treated rats. The reduction in vocalization is comparable to the reference drug sumatriptan. CONCLUSION: The findings provide the strong evidence for anti-migraine potential of ANE in rat models of migraine. In summary, therapeutic intervention with ANE treatment could be a promising strategy for prevention of migraine.


Subject(s)
Analgesics/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Areca , Migraine Disorders/drug therapy , Pain/drug therapy , Plant Extracts/therapeutic use , Analgesics/pharmacology , Analgesics/toxicity , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/toxicity , Blood Proteins/metabolism , Bradykinin , Female , Male , Mice , Migraine Disorders/metabolism , Nuts , Pain/metabolism , Phytotherapy , Plant Extracts/pharmacology , Plant Extracts/toxicity , Rats, Wistar , Toxicity Tests, Acute , Vocalization, Animal/drug effects
2.
Indian J Pharmacol ; 45(3): 232-6, 2013.
Article in English | MEDLINE | ID: mdl-23833364

ABSTRACT

OBJECTIVE: To evaluate the nephroprotective effect of methanolic extract of Hygrophila spinosa (HSME) (Acanthaceae) in (CP)-induced acute renal failure in rats. MATERIALS AND METHODS: HSME (250 mg/kg and 500 mg/kg body weight), were administered orally to male wistar albino rats.CP was used to induce acute renal failure. The parameters studied included blood urea and serum creatinine and malondialdehyde (MDA), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD) and GSH peroxidase activities. Histopathological examination was also carried out. RESULTS: The results revealed that HSME pretreatment signiûcantly reduced blood urea and serum creatinine levels elevated by CP administration. Furthermore, HSME signiûcantly attenuated CP-induced increase in MDA and decrease in reduced GSH, and CAT and SOD and GSH peroxidase activities in renal cortical homogenates. Additionally, histopathological examination showed that HSME markedly ameliorated CP-induced renal tubular necrosis. CONCLUSION: The results indicate that the aerial parts of H. spinosa are endowed with nephroprotective activity.


Subject(s)
Acanthaceae , Acute Kidney Injury/drug therapy , Plant Extracts/therapeutic use , Protective Agents/therapeutic use , Acute Kidney Injury/chemically induced , Acute Kidney Injury/metabolism , Acute Kidney Injury/pathology , Animals , Antineoplastic Agents , Catalase/metabolism , Cisplatin , Creatinine/blood , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Kidney Tubules/pathology , Male , Malondialdehyde/metabolism , Phytotherapy , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Urea/blood
3.
Indian J Pharmacol ; 44(5): 639-42, 2012.
Article in English | MEDLINE | ID: mdl-23112429

ABSTRACT

OBJECTIVE: Hygrophila spinosa (Acanthaceae) is traditionally used to treat urinary calculi. The present study aimed to evaluate the antiurolithiatic activity of methanolic extract of Hygrophila spinosa (Acanthaceae) in ethylene glycol induced nephrolithiasic rats. MATERIALS AND METHODS: Methanolic extract of Hygrophila spinosa (HSME) (250 and 500 mg/ kg body weight) was administered orally to male Wistar albino rats. Ethylene glycol (EG) was used to induce nephrolithiasis. The parameters studied included water intake, urinary volume, urinary pH, urinary and kidney oxalate and calcium, urinary magnesium and serum uric acid. RESULTS: Ethylene glycol feeding resulted in hyperoxaluria as well as increased renal excretion of calcium and serum uric acid along with decreased excretion of urinary magnesium. Treatment with HSME significantly reduced the elevated urinary oxalate, urinary calcium and serum uric acid with increase in reduced urinary magnesium. Ethylene glycol feeding also resulted in increased levels of calcium and oxalate in kidney which was decreased after the treatment with HSME. The increased deposition of stone forming constituents in the kidneys of ethylene glycol treated rats was significantly lowered by treatment with HSME. CONCLUSION: The results indicate that the aerial parts of Hygrophila spinosa are endowed with antiurolithiatic activity, thereby justifying its traditional claim.


Subject(s)
Acanthaceae , Ethylene Glycol/toxicity , Nephrolithiasis/chemically induced , Nephrolithiasis/drug therapy , Plant Extracts/therapeutic use , Animals , Female , Male , Nephrolithiasis/metabolism , Plant Extracts/isolation & purification , Rats , Rats, Wistar , Treatment Outcome
4.
J Chem Biol ; 5(1): 35-42, 2012 Jan.
Article in English | MEDLINE | ID: mdl-23049645

ABSTRACT

Currently phosphodiestrase5 (PDE5) inhibitors are the first-line treatment for erectile dysfunction. Drugs such as sildenafil and tadalafil are available as PDE5 inhibitors which are potent and reversible but lack selectivity with side effects such as headache, facial flushing, dyspepsia, and visual disturbances. We herein report for the first time novel condensed thienopyrimidines as evodiamine analogue and their effect on sexual behavior in male rats hitherto unreported. Novel synthetic evodiamine significantly showed improvement in male rat copulatory behavior. The test compound MKAC9 could be of promising importance in the treatment of sexual disorders like desire disorder or erectile dysfunction.FigureEvodiamine analogue on sexual behavior in male rats.

5.
J Complement Integr Med ; 9: Article 2, 2012 Jan 10.
Article in English | MEDLINE | ID: mdl-22499722

ABSTRACT

Diabetic neuropathic pain, an important microvascular complication in diabetes, is recognised as one of the most difficult types of pain to treat. The development of tolerance, inadequate relief, and potential toxicity of classical antinociceptives warrant the investigation of the newer agents to relieve this pain. Reactive oxygen/nitrogen species, increased oxidative stress, cytokines, and apoptosis are implicated in the pathogenesis of diabetic neuropathy. The aim of the present study was to explore the effect of methanolic extract of aerial parts of H. spinosa (HSME) on alloxan induced diabetic neuropathy in Wistar rats. Diabetic rats developed neuropathy after the third week of diabetes induction. Chronic treatment with HSME (250, 500, and 750 mg/kg body weight; p.o.) for 6 weeks starting from the 3rd week of alloxan injection showed significant increase in the pain threshold levels as compared to diabetic rats. HSME treated diabetic animals showed significant decrease in blood glucose level and increase in body weight as compared to diabetic control animals. The changes in lipid peroxidation status and antioxidant enzymes levels observed in sciatic nerve of diabetic rats were significantly restored by HSME treatment. Thus, the results suggest therapeutic potential of H. spinosa in treatment of diabetic neuropathy.


Subject(s)
Acanthaceae , Diabetes Mellitus, Experimental/complications , Diabetic Neuropathies/drug therapy , Hyperalgesia/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Acanthaceae/toxicity , Alloxan , Animals , Diabetes Mellitus, Experimental/chemically induced , Diabetic Neuropathies/etiology , Drug Administration Schedule , Female , Hyperalgesia/etiology , Male , Pain Measurement , Plant Components, Aerial , Plant Extracts/toxicity , Plants, Medicinal/toxicity , Rats , Rats, Wistar , Toxicity Tests, Acute , Treatment Outcome
6.
Indian J Exp Biol ; 49(8): 627-33, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21870431

ABSTRACT

The cerebral ischemia in rats was induced by occluding bilateral common carotid arteries (BCCAO) for 30 min., followed by 45 min reperfusion. BCCAO caused significant depletion in superoxide dismutase, catalase, glutathione, glutathione peroxidase, glutathione-S-transferase, glutathione reductase and significant increase in lipid peroxidation along with severe neuronal damage in the brain. All the alterations except depletion in glutathione peroxidase and glutathione-S-transferase levels induced by cerebral ischemia were significantly attenuated by 15 days pretreatment with methanolic extract of P. dactylifera fruits (100, 300 mg/kg), whereas 30 mg/kg dose was insignificant in this regard. These results suggest the possible use P. dactylifera against bilateral common carotid artery occlusion induced oxidative stress and neuronal damage.


Subject(s)
Antioxidants/therapeutic use , Arecaceae/chemistry , Brain Ischemia/prevention & control , Carotid Artery, Common/drug effects , Carotid Stenosis/drug therapy , Neuroprotective Agents/therapeutic use , Animals , Antioxidants/isolation & purification , Antioxidants/toxicity , Brain Ischemia/metabolism , Brain Ischemia/pathology , Carotid Artery, Common/metabolism , Carotid Artery, Common/pathology , Carotid Stenosis/metabolism , Carotid Stenosis/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Fruit/chemistry , Male , Mice , Neuroprotective Agents/isolation & purification , Neuroprotective Agents/toxicity , Oxidative Stress/drug effects , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Toxicity Tests, Acute
7.
J Diabetes Complications ; 25(2): 129-36, 2011.
Article in English | MEDLINE | ID: mdl-20462773

ABSTRACT

Erectile dysfunction (ED) is defined as the inability of the male to attain and maintain erection of penis sufficient to permit satisfactory sexual intercourse. Prevalence of impotence in diabetic men is ≥50%. The pathophysiology of diabetes-induced erectile dysfunction (DIED) is multifactorial and no single etiology is at the forefront. The proposed mechanisms of erectile dysfunction in diabetic patients includes elevated advanced glycation end-products, increased levels of oxygen free radicals, impaired nitric oxide synthesis, increased endothelin B receptor binding sites and up-regulated RhoA/Rho-kinase pathway, neuropathic damage and impaired cyclic guanosine monophosphate (cGMP)-dependent protein kinase-1. The treatment of DIED is multimodal. Treatment of the underlying hyperglycemia and comorbidities is of utmost importance to prevent or halt the progression of disease. Oral medications are considered as the first line therapy for management of DIED. If oral agents cannot be used or have insufficient efficacy despite appropriate dosing and education, second-line treatments should be addressed. When there is lack of efficacy or when there is dissatisfaction with other modalities, penile prostheses are often the best alternative for ED and are considered as the third line therapy for DIED. Future strategies in the evolution of the treatment of DIED are aimed at correcting or treating the underlying mechanisms of DIED.


Subject(s)
Diabetes Complications/epidemiology , Diabetes Complications/etiology , Diabetes Complications/therapy , Erectile Dysfunction/epidemiology , Erectile Dysfunction/etiology , Erectile Dysfunction/therapy , Animals , Diabetes Complications/metabolism , Diabetic Neuropathies/complications , Diabetic Neuropathies/epidemiology , Diabetic Neuropathies/metabolism , Diabetic Neuropathies/therapy , Erectile Dysfunction/metabolism , Glycation End Products, Advanced/adverse effects , Glycation End Products, Advanced/metabolism , Health , Humans , Male , Nitric Oxide/biosynthesis , Sexuality/physiology
8.
Food Chem Toxicol ; 48(12): 3412-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20849907

ABSTRACT

The hydroalcoholic extract of Areca catechu L. (ANE) nut was screened for its analgesic, anti-inflammatory and in vitro antioxidant potential. Three doses of ANE (250, 500 and 1000 mg/kg orally) were tested for analgesic and anti-inflammatory activities. Evaluation of analgesic activity of ANE was performed using hot plate and formalin test in mice. ANE showed maximum increase in hot plate reaction time (56.27%, p<0.01), while reduced the duration of licking/biting behaviors in first (39.45%, p<0.05) and second (92.71%, p<0.01) phases of the formalin test indicating significant analgesic activity. ANE reduced the paw edema considerably (86.79% inhibition after 24h, p<0.01) in dose-dependent manner compared to carrageenan-induced rat. In addition, in vitro antioxidant activity of ANE was investigated by total phenolic content (TPC) and hydrogen peroxide assay. The IC(50) observed in hydrogen peroxide assay was 83.14 µg/ml and TPC 120.56±21.09 mg QE/g. Altogether, these results suggest that the hydroalcoholic extract of Areca catechu could be considered as a potential analgesic, anti-inflammatory and antioxidant agent.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Areca/chemistry , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Antioxidants/chemistry , Areca/toxicity , Carrageenan , Edema/chemically induced , Edema/pathology , Edema/prevention & control , Ethanol , Female , Foot/pathology , Formaldehyde , Free Radical Scavengers/chemistry , Hot Temperature , Hydrogen Peroxide/chemistry , Inflammation/chemically induced , Inflammation/prevention & control , Male , Mice , Nuts/chemistry , Pain Measurement/drug effects , Phenols/analysis , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats , Rats, Wistar , Solvents , Water
SELECTION OF CITATIONS
SEARCH DETAIL
...